Modern options in personalized therapy of metastatic cutaneous melanoma
A great progress was recently achieved in metastatic melanoma therapy. New targeted therapies allow high efficacy expectations for personalized treatment approaches. BRAF-inhibitors significantly increase time to progression, overall survival and response rate in malignant melanoma patients. Vemuraf...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IP Habib O.N.
2014-09-01
|
Series: | Современная онкология |
Subjects: | |
Online Access: | https://modernonco.orscience.ru/1815-1434/article/view/26968 |